dalteparin has been researched along with Necrosis in 34 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Necrosis: The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although congenital afibrinogenemia is a rare autosomal recessive bleeding disorder, it can be more frequently encountered in countries where consanguineous marriages are common." | 7.81 | A case of congenital afibrinogenemia complicated with thromboembolic events that required repeated amputations. ( Işik, B; Karakukcu, M; Mutlu, FT; Ozdemir, MA; Patiroglu, T; Unal, E; Yilmaz, E, 2015) |
| "Warfarin-induced skin necrosis is a rare complication associated with the use of oral anticoagulants." | 7.72 | A case of warfarin skin necrosis despite enoxaparin anticoagulation in a patient with protein S deficiency. ( Alexander, JB; Ierardi, R; Tai, CY, 2004) |
| "An uncommon case of delayed-onset dalteparin-induced skin necrosis in an 83-year-old Caucasian female patient associated with heparin-induced thrombocytopaenia (HIT) presenting on day 30 following dalteparin therapy is reported." | 3.85 | Delayed-onset heparin-induced skin necrosis: a rare complication of perioperative heparin therapy. ( Gan, WK, 2017) |
| "Although congenital afibrinogenemia is a rare autosomal recessive bleeding disorder, it can be more frequently encountered in countries where consanguineous marriages are common." | 3.81 | A case of congenital afibrinogenemia complicated with thromboembolic events that required repeated amputations. ( Işik, B; Karakukcu, M; Mutlu, FT; Ozdemir, MA; Patiroglu, T; Unal, E; Yilmaz, E, 2015) |
| "Histopathological examination of the enoxaparin and rivaroxaban groups revealed that the skin was mostly normal or intact with minimal inflammation." | 3.80 | Effects of enoxaparin and rivaroxaban on tissue survival in skin degloving injury: an experimental study. ( Alabalik, U; Alemdar, C; Azboy, I; Bulut, M; Demirtaş, A; Uçar, Y, 2014) |
| " Coumarin-induced skin necrosis was a recurrent feature during oral anticoagulation therapy, forcing her physicians to treat her with nadroparin (Fraxiparin) for only a few months." | 3.72 | Late onset of clinical symptoms and recurrent ecchymotic skin lesions in a 12-year-old girl with a severe double heterozygous protein C deficiency. ( Alhenc-Gelas, M; Corazza, F; Demulder, A; Ferster, A; Loop, M, 2004) |
| "Warfarin-induced skin necrosis is a rare complication associated with the use of oral anticoagulants." | 3.72 | A case of warfarin skin necrosis despite enoxaparin anticoagulation in a patient with protein S deficiency. ( Alexander, JB; Ierardi, R; Tai, CY, 2004) |
| " The relationship between warfarin induced skin necrosis and level of anticoagulation was investigated." | 3.70 | Homozygous protein C deficiency: description of a new mutation and successful treatment with low molecular weight heparin. ( Andrew, M; Halton, J; Jardine, L; Johnston, M; Marlar, R; Massicotte, MP; Monagle, P; Vegh, P; Webber, C, 1998) |
| "Skin necrosis is a rare complication in intensive care unit." | 1.34 | [Nadroparin-induced skin necrosis then thrombocytosis in intensive care unit: difficulty in diagnosis]. ( Denninger, MH; Mantz, J; Paugam-Burtz, C; Perbet, S; Trouiller, P, 2007) |
| "Heparin necrosis is characterised by widespread life-threatening cutaneous necrosis and systemic thrombosis, in which fatal progression of disease can only be halted by stopping heparin therapy." | 1.33 | Generalised cutaneous necrosis: a complication of low-molecular-weight heparin. ( Knight, AG; Patel, GK, 2005) |
| "A 43-year-old white woman with adult respiratory distress syndrome developed localized dermal necrosis and thrombocytopenia secondary to subcutaneous administration of unfractionated heparin." | 1.30 | Enoxaparin-associated dermal necrosis: a consequence of cross-reactivity with heparin-mediated antibodies. ( Kollef, MH; Schaiff, RA; Tonn, ME, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (11.76) | 18.2507 |
| 2000's | 14 (41.18) | 29.6817 |
| 2010's | 14 (41.18) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez, DL | 1 |
| Peña-Romero, AG | 1 |
| Díaz-González, JM | 1 |
| Domínguez-Cherit, J | 1 |
| Askar, I | 1 |
| Erbas, MK | 1 |
| Gurlek, A | 1 |
| Loop, M | 1 |
| Ferster, A | 1 |
| Corazza, F | 1 |
| Alhenc-Gelas, M | 1 |
| Demulder, A | 1 |
| Perbet, S | 1 |
| Trouiller, P | 1 |
| Paugam-Burtz, C | 1 |
| Denninger, MH | 1 |
| Mantz, J | 1 |
| Pasha, AK | 1 |
| McBane Ii, RD | 1 |
| Byrne, EM | 1 |
| Khattab, A | 1 |
| Chen, F | 1 |
| Bhagavatula, R | 1 |
| Li, J | 1 |
| Inwald, G | 1 |
| Thomas, M | 1 |
| Gucalp, A | 1 |
| Parameswaran, R | 1 |
| Lacouture, M | 1 |
| Abou-Alfa, G | 1 |
| Soff, G | 1 |
| Azboy, I | 1 |
| Demirtaş, A | 1 |
| Bulut, M | 1 |
| Alabalik, U | 1 |
| Uçar, Y | 1 |
| Alemdar, C | 1 |
| Senel, S | 1 |
| Zorlu, P | 1 |
| Dogan, B | 1 |
| Acar, M | 1 |
| Ozdemir, MA | 1 |
| Işik, B | 1 |
| Patiroglu, T | 1 |
| Karakukcu, M | 1 |
| Mutlu, FT | 1 |
| Yilmaz, E | 1 |
| Unal, E | 1 |
| Schleich, C | 1 |
| Hansen, TJ | 1 |
| Kirby, JS | 1 |
| Neloska, L | 1 |
| Damevska, K | 1 |
| Pavleska, L | 1 |
| Vargas-Hitos, JA | 1 |
| Sabio, JM | 1 |
| Navarrete-Navarrete, N | 1 |
| Zamora-Pasadas, M | 1 |
| Jiménez-Alonso, J | 1 |
| Olah, Z | 1 |
| Bereczky, Z | 1 |
| Szarvas, M | 1 |
| Boda, Z | 1 |
| Karmegam, A | 1 |
| Desai, A | 1 |
| Peter, V | 1 |
| Raut, V | 1 |
| Yurttutan, S | 1 |
| Ozdemir, R | 1 |
| Erdeve, O | 1 |
| Calisici, E | 1 |
| Oncel, MY | 1 |
| Oguz, SS | 1 |
| Dilmen, U | 1 |
| Yazbek, MA | 1 |
| Velho, P | 1 |
| Nadruz, W | 1 |
| Mahayri, N | 1 |
| Appenzeller, S | 1 |
| Costallat, LT | 1 |
| Miguélez, A | 1 |
| Barrientos, N | 1 |
| López-Ríos, F | 1 |
| Vanaclocha, F | 1 |
| Iglesias, L | 1 |
| Scharf, Y | 1 |
| Hershkoviz, R | 1 |
| Tai, CY | 1 |
| Ierardi, R | 1 |
| Alexander, JB | 1 |
| Toll, A | 1 |
| Gallardo, F | 1 |
| Abella, ME | 1 |
| Fontcuberta, J | 1 |
| Barranco, C | 1 |
| Pujol, RM | 1 |
| Nadir, Y | 1 |
| Mazor, Y | 1 |
| Reuven, B | 1 |
| Sarig, G | 1 |
| Brenner, B | 1 |
| Krivoy, N | 1 |
| Criado, PR | 1 |
| Bernardelli, IM | 1 |
| Rivitti, EA | 1 |
| Sotto, MN | 1 |
| Vilella, MA | 1 |
| Valente, NY | 1 |
| Martins, JE | 1 |
| Daniels, AH | 1 |
| Wilson, CL | 1 |
| Harrison, RA | 1 |
| Fried, M | 1 |
| Kahanovich, S | 1 |
| Dagan, R | 1 |
| Tonn, ME | 1 |
| Schaiff, RA | 1 |
| Kollef, MH | 1 |
| Monagle, P | 1 |
| Andrew, M | 1 |
| Halton, J | 1 |
| Marlar, R | 1 |
| Jardine, L | 1 |
| Vegh, P | 1 |
| Johnston, M | 1 |
| Webber, C | 1 |
| Massicotte, MP | 1 |
| Lefebvre, I | 1 |
| Delaporte, E | 1 |
| Dejobert, Y | 1 |
| Catteau, B | 1 |
| Piette, F | 1 |
| Bergoend, H | 1 |
| Gan, WK | 1 |
| Peitsch, WK | 1 |
| Glorer, E | 1 |
| Dempfle, CE | 1 |
| Back, W | 1 |
| Bayerl, C | 1 |
| Goerdt, S | 1 |
| Moore, A | 1 |
| Lau, E | 1 |
| Yang, C | 1 |
| Mackool, B | 1 |
| Kuter, DJ | 1 |
| Roth, B | 1 |
| Debarbieux, S | 1 |
| Causeret, AS | 1 |
| Trzeciak, MC | 1 |
| Claudy, A | 1 |
| Patel, GK | 1 |
| Knight, AG | 1 |
34 other studies available for dalteparin and Necrosis
| Article | Year |
|---|---|
Nadroparin-induced skin necrosis: clinical manifestation of HIT-2 even in the absence of thrombocytopaenia.
Topics: Adult; Humans; Male; Nadroparin; Necrosis; Skin Diseases; Thrombocytopenia | 2016 |
Effects of heparin fractions on the prevention of skin necrosis resulting from adriamycin extravasation: an experimental study.
Topics: Animals; Antineoplastic Agents; Dalteparin; Doxorubicin; Extravasation of Diagnostic and Therapeutic | 2002 |
Late onset of clinical symptoms and recurrent ecchymotic skin lesions in a 12-year-old girl with a severe double heterozygous protein C deficiency.
Topics: Age of Onset; Anticoagulants; Child; Coumarins; DNA Mutational Analysis; Ecchymosis; Family Health; | 2004 |
[Nadroparin-induced skin necrosis then thrombocytosis in intensive care unit: difficulty in diagnosis].
Topics: Adult; Anticoagulants; Humans; Intensive Care Units; Male; Nadroparin; Necrosis; Skin; Thrombocytosi | 2007 |
Heparin Skin Necrosis in Heparin-Induced Thrombocytopenia.
Topics: Aged; Anticoagulants; Enoxaparin; Female; Humans; Injections; Necrosis; Skin Diseases; Thrombocytope | 2021 |
Rare presentation of enoxaparin-induced skin necrosis in a postoperative patient.
Topics: Anticoagulants; Enoxaparin; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Necrosis; Postop | 2022 |
A Rare Case of Enoxaparin-Induced Skin Necrosis Without Thrombocytopenia.
Topics: Abdomen; Adult; Anticoagulants; Drug Eruptions; Enoxaparin; Female; Humans; Necrosis; Skin Diseases | 2019 |
Skin necrosis induced by generic enoxaparin.
Topics: Aged; Anticoagulants; Drugs, Generic; Enoxaparin; Female; Humans; Male; Middle Aged; Necrosis; Skin; | 2013 |
Effects of enoxaparin and rivaroxaban on tissue survival in skin degloving injury: an experimental study.
Topics: Animals; Disease Models, Animal; Enoxaparin; Fibrinolytic Agents; Inflammation; Male; Morpholines; N | 2014 |
Successfully treated fingertip necrosis in an infant with primary Raynaud phenomenon.
Topics: Anticoagulants; Drug Therapy, Combination; Enoxaparin; Fingers; Humans; Infant; Male; Necrosis; Nife | 2014 |
A case of congenital afibrinogenemia complicated with thromboembolic events that required repeated amputations.
Topics: Afibrinogenemia; Amputation, Surgical; Anemia; Anticoagulants; Blood Coagulation Tests; Disease Prog | 2015 |
JAAD grand rounds quiz. Dusky bullae on the abdomen.
Topics: Abdominal Wall; Anticoagulants; Blister; Drug Eruptions; Enoxaparin; Female; Humans; Middle Aged; Ne | 2014 |
Enoxaparin-induced Skin Necrosis.
Topics: Aged; Anticoagulants; Comorbidity; Diagnosis, Differential; Enoxaparin; Fatal Outcome; Female; Human | 2015 |
Severe digital necrosis as the clinical onset of antiphospholipid syndrome.
Topics: Aged; Antiphospholipid Syndrome; Enoxaparin; Fibrinolytic Agents; Humans; Male; Necrosis | 2016 |
Coagulation: cascade!
Topics: Aged; Anticoagulants; Coumarins; Enoxaparin; Gangrene; Heparin; Humans; International Normalized Rat | 2011 |
Tissue necrosis after use of enoxaparin in total knee arthroplasty: a case report.
Topics: Anticoagulants; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Debridement; Enoxaparin; Fem | 2011 |
Intrauterine upper extremity thrombosis successfully treated with recombinant tissue plasminogen activator, enoxaparin and collagenase.
Topics: Collagenases; Enoxaparin; Fetal Diseases; Fibrinolytic Agents; Humans; Infant, Newborn; Male; Necros | 2012 |
Extensive skin necrosis induced by low-molecular-weight heparin in a patient with systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Drug Eruptions; Drug Therapy, Combination; Enoxaparin; Female; F | 2012 |
Necrotic livedo reticularis, multiple cholesterol emboli and ANCA.
Topics: Abdomen; Aged; Buttocks; Diagnosis, Differential; Embolism, Cholesterol; Enoxaparin; Humans; Hyperch | 2003 |
[Enoxaparin induced skin necrosis].
Topics: Aged; Anticoagulants; Atrial Fibrillation; Enoxaparin; Female; Humans; Necrosis; Skin; Skin Diseases | 2003 |
A case of warfarin skin necrosis despite enoxaparin anticoagulation in a patient with protein S deficiency.
Topics: Anticoagulants; Arterial Occlusive Diseases; Enoxaparin; Female; Fibrinolytic Agents; Heparin, Low-M | 2004 |
Low-molecular-weight heparin-induced skin necrosis: a potential association with pre-existent hypercoagulable states.
Topics: Aged; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Enoxaparin; Fo | 2005 |
A fatal case of enoxaparin induced skin necrosis and thrombophilia.
Topics: Aged; Anticoagulants; Diagnosis, Differential; Drug Eruptions; Enoxaparin; Factor V; Factor VIII; Fa | 2006 |
Childhood-onset skin necrosis resulting from protein C deficiency.
Topics: Blood Component Transfusion; Child, Preschool; Enoxaparin; Fibrinolytic Agents; Follow-Up Studies; H | 2007 |
Hepatitis C-associated leukocytoclastic vasculitis with anticardiolipin antibodies causing penile necrosis and deep venous thrombosis in the absence of cryoglobulinemia.
Topics: Antibodies, Anticardiolipin; Anticoagulants; Cryoglobulinemia; Debridement; Enoxaparin; Hepatitis C; | 2008 |
Enoxaparin-induced skin necrosis.
Topics: Adult; Anticoagulants; Enoxaparin; Female; Humans; Middle Aged; Necrosis; Skin | 1996 |
Enoxaparin-associated dermal necrosis: a consequence of cross-reactivity with heparin-mediated antibodies.
Topics: Adult; Antibodies; Anticoagulants; Cross Reactions; Drug Eruptions; Enoxaparin; Female; Heparin; Hum | 1997 |
Homozygous protein C deficiency: description of a new mutation and successful treatment with low molecular weight heparin.
Topics: Adult; Anticoagulants; Biomarkers; Bone Density; Child; Drug Eruptions; Enoxaparin; Female; Heparin; | 1998 |
[Enoxaparin-induced cutaneous necrosis localized on insulin lipodystrophies].
Topics: Anticoagulants; Enoxaparin; Female; Humans; Injections, Subcutaneous; Insulin; Lipodystrophy; Middle | 1997 |
Delayed-onset heparin-induced skin necrosis: a rare complication of perioperative heparin therapy.
Topics: Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Dalteparin; Diagnosis, Differenti | 2017 |
[Cutaneous necroses mainly on the extremities].
Topics: Aged; Aged, 80 and over; Anticoagulants; Dalteparin; Diagnosis, Differential; Extremities; Female; F | 2004 |
Dalteparin-induced skin necrosis in a patient with metastatic lung adenocarcinoma.
Topics: Adenocarcinoma; Anticoagulants; Dalteparin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle | 2007 |
[A necrotic plaque on the thigh].
Topics: Adult; Anticoagulants; Drug Eruptions; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; M | 2003 |
Generalised cutaneous necrosis: a complication of low-molecular-weight heparin.
Topics: Aged; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Necrosis; Skin; Tinzaparin | 2005 |